Mohammad Khan
Rheumatology · Oklahoma City, OKNPI 1699822379
Payments from drug & device makers
Across 712 payments — averaging $1403.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$343K
- Eli Lilly$331K
- Amgen$68K
- GSK$64K
- Pfizer$61K
- E.r. Squibb & Sons, L.L.C.$52K
- plus $79K from 26 others
Across 2 payments — averaging $721.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 39 | $342,827 |
| Eli Lilly | 24 | $331,264 |
| Amgen(2 entities) | 134 | $68,434 |
| GSK | 37 | $64,349 |
| Pfizer | 66 | $61,134 |
| E.r. Squibb & Sons, L.L.C. | 60 | $51,961 |
| AbbVie | 113 | $29,412 |
| Genentech, Inc. | 1 | $17,603 |
| UCB SA | 2 | $8,418 |
| Astrazeneca UK Limited | 1 | $5,195 |
| Sanofi US Services Inc. | 3 | $4,760 |
| EMD Serono, Inc. | 1 | $4,117 |
| UCB, Inc. | 71 | $4,074 |
| Aurinia Pharma U.S., Inc. | 3 | $2,107 |
| UCB GmbH | 1 | $780 |
| Sanofi | 26 | $679 |
| Lilly USA, LLC | 31 | $448 |
| Genentech USA, Inc. | 18 | $247 |
| Mallinckrodt Hospital Products Inc. | 17 | $216 |
| Radius Health, Inc. | 12 | $207 |
| Johnson & Johnson | 12 | $191 |
| Antares Pharma, Inc. | 10 | $156 |
| Mallinckrodt Enterprises LLC | 9 | $151 |
| Sanofi-aventis U.S. LLC | 2 | $106 |
| Zyla Life Sciences, Inc. | 6 | $82 |
| Actelion Pharmaceuticals US, Inc. | 3 | $70 |
| Nalu Medical, Inc. | 1 | $61 |
| AstraZeneca | 4 | $56 |
| Merck | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$999,179 in reported general payments places this provider in the 90th percentile of 67 rheumatology providers in Oklahoma.
Other rheumatology in Oklahoma City
- Christine CoddingOklahoma City$2.8M
- Latisha HeinlenOklahoma City$1.9M
- Cristina ArriensOklahoma City$1.8M
- Joan MerrillOklahoma City$1.8M
- Fahed HamadehOklahoma City$321K
- William SchnitzOklahoma City$290K
- Michael PickrellOklahoma City$163K
- John GoetzingerOklahoma City$38K
- Judith JamesOklahoma City$18K
- Robert ArthurOklahoma City$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.